Clinical Trials Browser

Completed × Carcinoma × ARQ 197 × Clear all

NCT01755767 2021-04-06

METIV-HCC

Phase 3 Completed

383 enrolled 17 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT00988741 2013-02-28

Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy

Phase 2 Completed

Carcinoma